785 results on '"Dienstmann, Rodrigo"'
Search Results
2. The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models
3. Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer
4. A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
5. Precision medicine for urothelial carcinoma: An international perspective
6. Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
7. Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study
8. Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study
9. Clinical and genomic characterisation of early-onset pancreatic cancer
10. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
11. RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon
12. Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients
13. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
14. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
15. Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
16. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
17. Evaluation of homologous recombination repair (HRR) status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assays.
18. Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean
19. Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
20. Landscape de biomarcadores preditivos tumorais e agnósticos de tumor na Oncologia
21. Big data e Oncologia de Precisão
22. Oncologia de Precisão
23. PI3K activation promotes resistance to eribulin in HER2-negative breast cancer
24. Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges.
25. The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients.
26. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry
27. Association of KRAS G12C Status with Age at Onset of Metastatic Colorectal Cancer
28. Evaluation of homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assays
29. Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer
30. Association of KRAS G12C status with age at onset of metastatic colorectal cancer in the Brazilian population: A multicenter analysis of a molecular profile database (RAS, BRAF and MSI status).
31. FIGURE 4 from Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression
32. Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis
33. The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer
34. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
35. Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
36. Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
37. Association of KRAS G12C Status with Age at Onset of Metastatic Colorectal Cancer
38. Weakly supervised deep learning predicts immunotherapy response in solid tumors based on PD-L1 expression
39. Figure S3 from Early-Stage Breast Cancer Detection in Breast Milk
40. Data from Early-Stage Breast Cancer Detection in Breast Milk
41. Fluorouracil Bolus Use in Infusional Regimens Among Oncologists—A Survey by Brazilian Group of Gastrointestinal Tumors
42. Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
43. Precision oncology: separating the wheat from the chaff
44. Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non–Small-Cell Lung Cancer?
45. Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil
46. Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in access
47. Early-Stage Breast Cancer Detection in Breast Milk
48. Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective
49. Challenges and opportunities in building a health economic framework for personalized medicine in oncology
50. Precision cancer medicine: Concepts, current practice, and future developments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.